Access to information and documents on these webpages (the “Information”) has been restricted by law. You are asked to read through the following information and to make the requested confirmation every time you access restricted information.
INFORMATION IS RESTRICTED AND IS NOT INTENDED FOR, AND MUST NOT BE ACCESSED BY, OR DISTRIBUTED OR DISSEMINATED, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO PERSONS RESIDENT OR PHYSICALLY PRESENT IN THE UNITED STATES OF AMERICA OR ANY STATE OF THE UNITED STATES (TOGETHER, THE “UNITED STATES”), AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH IT WOULD CONSTITUTE A VIOLATION OF THE LAWS OR REGULATIONS OF SUCH JURISDICTION.
The Information is not an offer for sale of securities in the United States. The shares in Bioretec Ltd (the “Shares”) have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold within the United States absent registration or an applicable exemption from registration thereunder.
The Shares have also not been and will also not be registered under the applicable securities laws of the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore and South Africa and, subject to certain limited exemptions, may not be offered or sold in or into or for the account or benefit of any person having a registered address in, or located or resident in, the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa. There will be no public offer of the Shares in the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa.
The Information is directed only at (i) persons who are outside the United Kingdom or (ii) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2) of the Order (all such persons together being referred to as “relevant persons”). Any investment activity to which the Information relates will only be available to and will only be engaged with, relevant persons. Any person who is not a relevant person should not act or rely on the Information.
In any other Member State of the European Economic Area (the "EEA"), other than Finland, where Regulation (EU) 2017/1129 (as amended, the "Prospectus Regulation") is applicable, this Information is only being distributed to and is only directed at persons in the EEA who are "qualified investors" within the meaning of article 2(e)of the Prospectus Regulation.
Access to the Information may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access the Information. All persons residing outside of Finland who wish to have access to the Information should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access the Information, or require registration or approval for any acquisition of securities by them. No such registration or approval has been obtained outside Finland. Danske Bank and its representatives assume no responsibility if there is a violation of applicable law and regulations by any person.
ONLY PERSONS RESIDENT AND PHYSICALLY PRESENT IN FINLAND MAY PARTICIPATE IN THE OFFERING THROUGH THESE WEBPAGES.
